Crossmark

Breast cancer: agreement between residual tumor size after neoadjuvant chemotherapy measurement with different imaging methods and the histological data

Crossref DOI link: https://doi.org/10.1007/s44326-024-00038-7

Published Online: 2024-09-18

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Fattacciu, Liala M. https://orcid.org/0009-0000-5978-7862
Pinna, Claudia

Fancellu, Alessandro

Piscopo, Leandra

Conti, Ilaria

Solinas, Maria Giuliana

Assenza, Andrea

Scaglione, Mariano

Masala, Salvatore
License Information

Text and Data Mining valid from 2024-09-18

Version of Record valid from 2024-09-18
More Information

Article History

Received: 30 April 2024

Accepted: 6 September 2024

First Online: 18 September 2024

Declarations

:

: The authors declare no conflict of interest.

: It was not necessary to obtain patients’ written informed consent.

: Not applicable.

Document is current

Any future updates will be listed below